Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
170,107,714
-
Total 13F shares
-
152,670,605
-
Share change
-
-1,149,065
-
Total reported value
-
$7,396,593,388
-
Put/Call ratio
-
108%
-
Price per share
-
$48.47
-
Number of holders
-
292
-
Value change
-
-$42,512,386
-
Number of buys
-
155
-
Number of sells
-
119
Institutional Holders of ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) as of Q2 2020
As of 30 Jun 2020,
ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) was held by
292 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
152,670,605 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, BlackRock Inc., JANUS HENDERSON GROUP PLC, CITADEL ADVISORS LLC, STATE STREET CORP, AMERIPRISE FINANCIAL INC, and D. E. Shaw & Co., Inc..
This page lists
292
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.